![Overall survival curve by treatment method. The 5-year overall survival... | Download Scientific Diagram Overall survival curve by treatment method. The 5-year overall survival... | Download Scientific Diagram](https://www.researchgate.net/publication/328286526/figure/fig2/AS:682002189660161@1539613401325/Overall-survival-curve-by-treatment-method-The-5-year-overall-survival-rate-and-median.png)
Overall survival curve by treatment method. The 5-year overall survival... | Download Scientific Diagram
![5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/3ff708fc-ff94-456b-b4b1-40e9cd97d4eb/gr1.gif)
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
![Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival Xu X, Li M, Hu J, Chen Z, Yu J, Dong Y, Sun C, Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival Xu X, Li M, Hu J, Chen Z, Yu J, Dong Y, Sun C,](https://www.cancerjournal.net/articles/2018/14/7/images/JCanResTher_2018_14_7_1525_247724_f6.jpg)
Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival Xu X, Li M, Hu J, Chen Z, Yu J, Dong Y, Sun C,
![Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-018-0155-7/MediaObjects/41408_2018_155_Fig1_HTML.png)
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
![4baseCare on Twitter: 4baseCare on Twitter:](https://pbs.twimg.com/media/FPpvkhUaIAAqXds.jpg)
4baseCare on Twitter: "Research data suggests that 5-year survival rates in different subtypes of Cholangiocarcinoma vary in different stages of the disease. LINK: https://t.co/yh5Cbkcr1j #MedTwitter https://t.co/nhmwIeZAg9" / Twitter
![PDF] Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study | Semantic Scholar PDF] Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7cbf64e0a2a5bc6572dc331e433efae660922309/4-Figure1-1.png)
PDF] Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study | Semantic Scholar
![P48.05 Is Relapse-Free Survival at 2-Years an Appropriate Surrogate for Overall Survival at 5-Years in EGFR-mutated Resected NSCLC? - Journal of Thoracic Oncology P48.05 Is Relapse-Free Survival at 2-Years an Appropriate Surrogate for Overall Survival at 5-Years in EGFR-mutated Resected NSCLC? - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/9545bc75-143d-4d88-964c-180f01ca18fa/fx1.jpg)
P48.05 Is Relapse-Free Survival at 2-Years an Appropriate Surrogate for Overall Survival at 5-Years in EGFR-mutated Resected NSCLC? - Journal of Thoracic Oncology
![Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study | Journal of Clinical Oncology Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2019/jco.2019.37.issue-28/jco.19.00934/20190919/images/large/jco.19.00934t2.jpeg)
Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study | Journal of Clinical Oncology
Five-year overall survival by era. (A) Kaplan-Meier estimates of OS... | Download Scientific Diagram
![Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy | SpringerLink Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11255-019-02181-7/MediaObjects/11255_2019_2181_Fig1_HTML.png)
Assessment of 5-year overall survival in bladder cancer patients with incidental prostate cancer identified at radical cystoprostatectomy | SpringerLink
![5-year overall survival almost doubled with pembrolizumab for metastatic NSCLC patients with a PD-L1 TPS ≥ 50% and without EGFR/ALK alterations - BJMO 5-year overall survival almost doubled with pembrolizumab for metastatic NSCLC patients with a PD-L1 TPS ≥ 50% and without EGFR/ALK alterations - BJMO](https://www.bjmo.be/app/uploads/2021/11/Banner-KN024-EN-V1-2400x1800-NOV21-1024x737.jpg)
5-year overall survival almost doubled with pembrolizumab for metastatic NSCLC patients with a PD-L1 TPS ≥ 50% and without EGFR/ALK alterations - BJMO
![5-year overall survival rates of Different Tumor Stages. After Log-rank... | Download Scientific Diagram 5-year overall survival rates of Different Tumor Stages. After Log-rank... | Download Scientific Diagram](https://www.researchgate.net/publication/311565442/figure/fig1/AS:438095574245378@1481461532167/5-year-overall-survival-rates-of-Different-Tumor-Stages-After-Log-rank-analysis-no.png)
5-year overall survival rates of Different Tumor Stages. After Log-rank... | Download Scientific Diagram
![Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database | BMC Cancer | Full Text Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-021-08399-y/MediaObjects/12885_2021_8399_Fig2_HTML.png)
Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database | BMC Cancer | Full Text
![Cancers | Free Full-Text | Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer Cancers | Free Full-Text | Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer](https://www.mdpi.com/cancers/cancers-11-01239/article_deploy/html/images/cancers-11-01239-g006.png)
Cancers | Free Full-Text | Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer
![Kaplan-Meier survival curves comparing 5-year overall survival (OS) and... | Download Scientific Diagram Kaplan-Meier survival curves comparing 5-year overall survival (OS) and... | Download Scientific Diagram](https://www.researchgate.net/publication/333780703/figure/fig1/AS:769686505541634@1560518971977/Kaplan-Meier-survival-curves-comparing-5-year-overall-survival-OS-and-recurrence-free.png)
Kaplan-Meier survival curves comparing 5-year overall survival (OS) and... | Download Scientific Diagram
![Overall survival. a The 5-year overall survival (OS) was 64.9%. b The... | Download Scientific Diagram Overall survival. a The 5-year overall survival (OS) was 64.9%. b The... | Download Scientific Diagram](https://www.researchgate.net/publication/344003199/figure/fig1/AS:932818167275522@1599412590811/Overall-survival-a-The-5-year-overall-survival-OS-was-649-b-The-5-year-survival.png)